par Efficace, F;Biganzoli, Laura ;Piccart-Gebhart, Martine ;Coens, C;Van Steen, K;Cufer, T;Coleman, R;Calvert, H;Gamucci, T;Twelves, C.;Fargeot, Pierre;Bottomley, A;EORTC-BCG-IDBBC-NDDG,
Référence European journal of cancer, 40, 7, page (1021-1030)
Publication Publié, 2004-05
Référence European journal of cancer, 40, 7, page (1021-1030)
Publication Publié, 2004-05
Article révisé par les pairs
Titre: |
|
Auteur: | Efficace, F; Biganzoli, Laura; Piccart-Gebhart, Martine; Coens, C; Van Steen, K; Cufer, T; Coleman, R; Calvert, H; Gamucci, T; Twelves, C.; Fargeot, Pierre; Bottomley, A; EORTC-BCG-IDBBC-NDDG, |
Informations sur la publication: | European journal of cancer, 40, 7, page (1021-1030) |
Statut de publication: | Publié, 2004-05 |
Sujet CREF: | Sciences bio-médicales et agricoles |
Mots-clés: | Breast cancer |
Prognostic factor | |
Quality of life | |
Randomised controlled trial | |
MeSH keywords: | Adult |
Aged | |
Antineoplastic Combined Chemotherapy Protocols -- therapeutic use | |
Breast Neoplasms -- drug therapy | |
Cyclophosphamide -- administration & dosage | |
Disease-Free Survival | |
Doxorubicin -- administration & dosage | |
Female | |
Humans | |
Middle Aged | |
Neoplasm Metastasis -- drug therapy | |
Paclitaxel -- administration & dosage | |
Prognosis | |
Quality of Life | |
Survival Analysis | |
Note générale: | Clinical Trial |
Clinical Trial, Phase III | |
Journal Article | |
Multicenter Study | |
Randomized Controlled Trial | |
Research Support, Non-U.S. Gov't | |
Langue: | Anglais |
Identificateurs: | urn:issn:0959-8049 |
info:doi/10.1016/j.ejca.2004.01.014 | |
info:pii/S0959804904001212 | |
info:scp/11144355162 | |
info:pmid/15093577 |